Galmed Pharmaceuticals (EOCN) Cash from Investing Activities (2013 - 2026)
Galmed Pharmaceuticals (EOCN) reported Cash from Investing Activities of $2.24 million for Q2 2026, compared with -$4.57 million a year earlier.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Galmed Pharmaceuticals' Cash from Investing Activities came in at $7.19 million; for FY2025, it was -$10,000.
- By year, Cash from Investing Activities came in at $1.5 million in FY2024 (+87.3%), $800,000 in FY2023 (-95.4%), $17.56 million in FY2022 (+53.2%) and $11.46 million in FY2021 (-30.7%).
- Five-year quarterly Cash from Investing Activities spans a low of -$4.57 million in Q2 2025 and a high of $6.39 million in Q4 2021.
- The high point for year-over-year Cash from Investing Activities in five years was Q2 2024 (growth of 97.4%); the low point was Q2 2023 (a decline of 83.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $152,000 (Q1 2026), $4.79 million (Q4 2025) and -$3,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Galmed Pharmaceuticals | 420,034.32 | 420,034.32 | - | 2.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.24 Mn |
| Mar 31, 2026 | 152,000.00 |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -4.57 Mn |
| Mar 31, 2025 | -231,000.00 |
| Dec 31, 2024 | -940,000.00 |
| Sep 30, 2024 | 614,000.00 |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 432,000.00 |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | -3.54 Mn |
| Jun 30, 2023 | 705,000.00 |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Sep 30, 2022 | 5.13 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | 6.31 Mn |
| Dec 31, 2021 | 6.39 Mn |
| Sep 30, 2021 | 4.55 Mn |
API Access
Galmed Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();